Nitrate (NO3−) is a relatively inert anion that can be converted in vivo to bioactive nitrogen oxides including nitric oxide (NO) (30). The main dietary sources of inorganic nitrate are vegetables (e.g., spinach and beetroot), processed meats (where it is added as a preservative), and water (8). Circulating plasma NO3− can be actively taken up by salivary glands, excreted in saliva, and reduced to NO2− by commensal bacteria in the oral cavity (32). When swallowed in the acidic environment of the stomach, NO2− is further converted to NO, whereas the remainder is absorbed and increases circulating plasma [NO2−]. This NO2− can be further reduced to NO, particularly in tissues that are relatively hypoxic, such as contracting skeletal muscle (32), and play a significant role in a myriad of physiological processes, among which, at the skeletal muscle level, are the increase in blood flow and a partial inhibition of mitochondrial respiration (40).
This NO3−–NO2−–NO pathway represents an alternative (and differently regulated) system compared to the classic L-arginine NO synthesis pathway and is involved in important physiological processes such as the regulation of blood flow (17) and blood pressure (29), cell signaling and glucose homeostasis (9), and tissue responses to hypoxia (32).
Recent studies have demonstrated that single or short-term (3–6 d) dietary nitrate supplementation in the form of sodium nitrate (30,31) as well as beetroot juice (2,27,41): a) has a very limited effect on V˙O2max, maintaining or improving power output or speed at V˙O2max (23); b) can induce a significant reduction of the O2 cost during steady-state submaximal exercise, in association with no increase in blood lactate concentration (2,28,31), indicating that the lowered oxygen uptake after nitrate intake is not compensated by an enhanced anaerobic energy turnover; c) does not change the speed of the primary phase of the V˙O2 response while exercising at a moderate intensity (2,28,41), although it results in a small but significant speeding of V˙O2 kinetics in situations where muscle O2 supply is more likely to be compromised, for example, in older adults (26) and in young adults performing high-intensity exercise (7); and d) may enhance performance across events where there is a significant oxidative contribution to energy turnover (23).
The precise mechanisms responsible for these effects have yet to be elucidated but are thought to be attributable to NO-mediated enhancements of muscle contractile function (1,18) and/or mitochondrial efficiency (30).
Despite the considerable evidence of the positive ergogenic effects of nitrate supplementation in recreationally active and moderately trained individuals (with a maximal oxygen uptake approximately 50–55 mL·kg−1·min−1), recent studies have failed to show improved exercise performance after dietary nitrate supplementation in elite cyclists (4,11,13,43), cross-country skiers (36), and runners (6). The reason(s) for the lack of effects observed in elite athletes is(are) not understood. It has been hypothesized that adaptations elicited by endurance training may play a role in nitrate supplementation response (4). Indeed, trained subjects seem characterized by a greater activity and presence of endothelial NO synthase (eNOS), the enzyme responsible for endogenous generation of NO (20,33). An increase in eNOS activity may decrease the production of NO from nitrate and thus attenuate the benefits from nitrate supplementation (20). Moreover, highly trained athletes have higher plasma levels of nitrate and nitrite than sedentary subjects (42), such that the response to a standard dose of nitrate may be diminished. Interestingly, a limited number of responders were identified both in elite cyclists (13,43) and in elite runners (6), indicating that aerobic fitness level may not be the only factor affecting the ergogenic effects of nitrate supplementation. In addition, different exercise modalities (i.e., running, cycling, etc), exercise testing protocol, and supplementation regime (acute/chronic, different nitrate concentrations) have been used in aforementioned studies, limiting the extent to which inferences on the effects of fitness on the efficacy of nitrate can be made.
No study to date has directly compared whether highly trained subjects respond to nitrate supplementation differently from sedentary or recreationally active individuals in the same experimental conditions. Thus, the aim of this study was to investigate whether the individual aerobic fitness level influences the ergogenic effect of nitrate supplementation on: i) typical parameters of oxidative metabolism such as the maximal oxygen uptake (V˙O2max), the O2 cost of exercise and kinetics of pulmonary V˙O2 after the onset of moderate-intensity exercise; and ii) exercise performance. The enhancing aspects of NO3− supplementation on the physiological response to exercise and performance will be correlated with resting plasma [NO3−] and [NO2−] levels and/or their changes after supplementation. We hypothesize that: 1) the ergogenic effects of nitrate supplementation are correlated with aerobic fitness level; and 2) the different responses among subjects with a wide range of physical fitness may be explained on the basis of plasma [NO3−] and [NO2−] changes.
Twenty-one young men (mean age, 22.7 ± 1.8 yr; body mass, 62.2 ± 10.5 kg; height, 1.71 ± 0.07 m; body mass index, 21.1 ± 2.3 kg·m−2) were selected from a larger population, with respect to their fitness levels by means of a questionnaire on physical activity (IPAQ-SF), and volunteered to participate in this study. Six subjects were actively involved in structured training programs and, although endurance training formed a large part of their training routine, they also undertook regular resistance conditioning. Three of these athletes were participants in national and international competitions. Four subjects trained three to four times per week and were participating in regional-level official competitions at the time of data collection. Seven participants were recreationally active individuals who engaged in a variety of activities (e.g., weightlifting, running, and team sports) less than two times per week. Four subjects were young university students sedentary or engaging in exercise for less than 90 min·wk−1. All participants were nonsmokers, normotensive, and were not assuming any drugs. The procedures used in this study were approved by the local ethics committee. All subjects gave their written informed consent after an explanation of the experimental procedures and before commencement of the study.
Each participant visited the laboratory on five separate occasions. On their first visit, anthropometric measurements and an incremental exercise (pre-examination) test to determine peak oxygen uptake (V˙O2peak) and the gas exchange threshold (GET) were performed. The protocol began with subjects running at 7–10 km·h−1 for 6 min, according to their presumed fitness level estimated by IPAQ-SF; then, the belt speed was increased by 1 km·h−1·min−1 until volitional exhaustion. The GET was determined as previously described (3) to calculate the treadmill speed that would require 80% of the individual GET (moderate-intensity exercise). The peak values of the main cardiovascular, respiratory, and metabolic parameters were taken as the highest 30-s mean value attained before the subject’s volitional exhaustion (Table 1). According to Rowell (39), subjects were divided into three groups based on their V˙O2peak value (low aerobic fitness (Low, n = 8), V˙O2peak range, 28.2–44.1 mL·kg−1·min−1; moderate aerobic fitness (Mod, n = 7), V˙O2peak range, 45.5–57.1 mL·kg−1·min−1; high aerobic fitness (High, n = 6), V˙O2peak range, 63.9–81.7 mL·kg−1·min−1). Two days after they carried out a 3-km running test on a 400-m outdoor track with no dietary supplementation (preintervention control) to gain familiarity with this test.
Subsequently, each subject was randomly assigned in a double-blind, crossover design to follow 6 d of supplementation with either sodium nitrate (NITR) (approximately 5.5 mmol·d−1; Sigma, Italy) or the placebo (PLA) (sodium chloride, 8.0 mmol·d−1; Sigma, Italy) dissolved in water. The daily dose was ingested once before breakfast. The different solutions could not be distinguished by taste or appearance. On day 5 of both supplementation periods, subjects underwent incremental exercise testing and two repetitions of a constant load moderate-intensity exercise. On day 6, the subjects repeated two constant load-moderate-intensity exercises and performed a 3-km time trial (see below for further details). The last ingestion (nitrate or placebo) was 3.5 ± 0.5 h before the exercise tests. Athletes received nutritional guidelines to eat the same amount of moderate- to high-nitrate-content foods (green vegetables, beetroot, strawberries, grapes, and tea). The subjects were also required to abstain from using antibacterial mouthwash and chewing gum, as these are known to destroy the oral bacteria responsible for the reduction of NO3− to NO2− (15). A 14-day washout separated the supplementation periods.
The subjects were instructed to arrive at the laboratory in a rested and fully hydrated state and to avoid strenuous exercise in the 24 h preceding each testing session. In addition, they were told to avoid alcohol and caffeine intake 48 h before the exercise test. All laboratory exercise tests were carried out in a well-ventilated laboratory at 19°C–21°C on a motorized treadmill (Jaeger, Germany) set at a 1% gradient.
The subjects initially performed a ramp incremental exercise test for the determination of V˙O2peak and GET. The protocol began with subjects running at the speed requiring 80% of the individual GET for 6 min; then the belt speed was increased by 1 km·h−1·min−1 until volitional exhaustion. The peak values of the main cardiovascular, respiratory, and metabolic parameters were taken as the highest 30-s mean value attained before the subject’s volitional exhaustion. On days 5 and 6 of both supplementation periods, the subjects completed two 6-min bouts of moderate-intensity running (80% GET) for the determination of pulmonary V˙O2 kinetics.
As for running performance, participants completed a 3-km running time trial on a 400-m outdoor track. To minimize the variability in pacing strategy (i.e., suboptimal or inconsistent pacing strategies) reported to occur at the start of a self-paced time trial independent of any intervention, the participants were encouraged to begin time trials based on their experiences in preliminary trials. For this reason, the participants were provided with feedback on their lap times for the first three laps but were blinded to exercise time thereafter. Performance times were recorded by using two synchronized stopwatches.
Pulmonary ventilation (V˙E, in BTPS), O2 consumption (V˙O2), and CO2 output (V˙CO2), both in STPD, were determined breath by breath by a metabolic cart (Vmax29c; SensorMedics, Bilthoven, The Netherlands). Expiratory flow was determined by a mass flow sensor (hot wire anemometer). V˙O2 and V˙CO2 were determined by continuously monitoring PO2 and PCO2 at the mouth throughout the respiratory cycle and from established mass balance equations. Gas exchange ratio (RQ) was calculated as V˙CO2 / V˙O2. Heart rate (HR) was determined from the ECG signal. At rest and at various times (1, 3, and 5 min) during recovery, 20 μL of capillary blood was obtained from a preheated earlobe for the determination of blood lactate concentration ([La]b) by an enzymatic method (Biosen 5030; EKF, Cosmed, Italy) both for laboratory and field tests.
V˙O2 kinetics were evaluated during transitions from rest to constant load exercise. Breath-by-breath V˙O2 values obtained during the four repetitions of the exercises were time aligned and then superimposed for each subject. Mean V˙O2 values every 10 s were calculated. Data obtained during the first 20 s of the transition (“cardiodynamic” phase) (37) were excluded from analysis. Thus, V˙O2 kinetics analysis focused on “phase 2” (or “fundamental” component) of the response, which more closely reflects gas exchange kinetics occurring in skeletal muscles (16).
To mathematically evaluate the V˙O2 kinetics, data were first fitted by a monoexponential function of the type:
where yBAS indicates the V˙O2 value at baseline; Af the amplitude of the V˙O2 response calculated between the baseline value and the steady-state value for the fundamental component; TDf is the time delay, and τf is the time constant of the function for the fundamental component.
To check the presence of a slow component of the kinetics (24), data were also fit by a double exponential function of the type:
where As, TDs, and τs indicate, the amplitude, the time delay, and the time constant of the slow component of the kinetics, respectively. No slow component was observed in all the constant load exercises both for NITR and PLA.
Resting blood sample was collected to determine plasma levels of nitrate and nitrite both on days 5 and 6. Venous blood was drawn from the antecubital vein into a 5-mL EDTA vacutainer tube (Vacutainer, Becton Dickinson, USA). Plasma was immediately separated by centrifuge (5702R, Eppendorf, Germany) at 1000g for 10 min at 4°C. Plasma samples were then ultrafiltered through a 10-kd molecular weight cutoff (AmiconUltra; Millipore, EMD Millipore Corporation, Billerica, MA) using a ultracentrifuge (4237R, ALC, Italy) at 14,000g for 60 min at 4°C to reduce background absorbance due to the presence of hemoglobin. The ultrafiltered plasma was recovered and used to measure nitrite and nitrate concentration. We used a commercial colorimetric assay kit (Cayman Chemical, USA), which provides an accurate and convenient method for measurement of nitrate and nitrite concentration. Samples were read by the addition of Griess reagents at 545 nm by a microplate reader spectrophotometer (Infinite M200, Tecan, Austria). A linear calibration curve was computed from pure nitrite and nitrate standard. All samples were determined in duplicate, and the interassay coefficient of variation was in the range indicated by the manufacturer.
Results are expressed as mean ± SD. A two-way mixed-design ANOVA with repeated measures (independent measures on aerobic fitness level and repeated measures on supplementation) has been used to examine the effects of intervention, aerobic fitness level, and the interaction between the two. Post hoc analysis was completed using Bonferroni multiple comparisons. Significance level was set at P < 0.05. When significant effects of intervention were found, a Student t-test for paired data was used to determine differences between PLA and NITR conditions. Pearson statistical test and the square of Pearson correlation coefficient (r2) have been used to examine the relationship between variables. All statistical procedures were completed using Prism 6.0 (GraphPad Software, CA, USA).
Incremental exercise (IE)
Mean ± SD peak values of the main cardiovascular, respiratory, and metabolic parameters obtained in Low, Mod, and High are shown in Table 2. All groups attained peak HR values at approximately 95% of the age predicted maximum. Thus, also taking into account RQ, [La]b, and rate of perceived exertion peak values, it can be assumed that maximum exercise capacity had been reached in each group. As expected, speed and V˙O2peak values were lower in Low than in Mod, and the latter achieved lower peak values than High. Gas exchange threshold occurred at 76.8% ± 6.2%, 83.5% ± 4.3%, and 86.9% ± 6.2% of V˙O2peak in Low, Mod, and High, respectively. For all the variables, no differences were observed between PLA and NITR in the three groups.
Constant load exercise
Mean ± SD V˙O2 values over the final 30 s of moderate exercise are shown in Figure 1A. There was a progressive increase of O2 cost of exercise in Low, Mod, and High according to the different absolute intensity (80% of GET) of exercise. A significantly lower V˙O2 was observed in NITR versus PLA both for Low and Mod (9.8% and 7.3%, respectively), whereas no change was found in High. In Figure 1B, individual percentage reduction of V˙O2 at steady state of all subjects are plotted versus the corresponding V˙O2peak value. A highly significant linear relationship was observed with lower-fit subjects showing a greater reduction of oxygen cost of exercise. The observed r2 value indicates that 80% of V˙O2SS variability can be explained in differences in aerobic fitness level. The same significant correlation (r2 = 0.72; P < 0.0001) was observed between GET and individual percentage reduction of V˙O2 at steady state. V˙CO2, RQ, [La]b, V˙E, and HR values were not significantly different between two conditions in the three groups.
As for the kinetics of adjustment of V˙O2 during constant load exercise, in NITR, a reduction of the amplitude of pulmonary V˙O2 response relative to PLA was observed in Low (1.23 ± 0.13 vs 1.37 ± 0.12 L·min−1, respectively), and Mod (1.54 ± 0.30 vs 1.72 ± 0.24 L·min−1, respectively), whereas no difference was observed in High (2.09 ± 0.15 vs 2.19 ± 0.19 L·min−1, respectively). Resting V˙O2, τf, and TDf were not affected by supplementation in the three groups.
Three-kilometer time trial results are shown in Figure 2A. There was a progressive reduction of finish time according to the aerobic fitness level of the subjects. In NITR, the time to cover 3 km was statistically lower than in PLA both for Low (886 ± 74 vs 910 ± 82 s; P = 0.0002) and Mod (723 ± 90 vs 734 ± 93 s; P = 0.0002). Performance did not change in High (627 ± 30 vs 629 ± 28 s in NITR and PLA, respectively). [La]b values were not statistically different in Low (7.4 ± 2.3 vs 7.3 ± 2.5 mM), Mod (9.4 ± 1.6 vs 10.6 ± 1.9 mM) and High (10.1 ± 3.5 vs 8.4 ± 3.0 mM) for conditions NITR and PLA, respectively. In Figure 2B, individual 3-km time trial difference of all subjects are plotted versus the corresponding V˙O2peak value. A significant inverse linear relationship was observed with lower-fit subjects showing a higher improvement in performance. The observed r2 value indicates that more than 75% of the 3-km time trial difference variability can be explained in differences in aerobic fitness level. The same significant correlation (r2 = 0.70; P < 0.0001) was observed between GET and individual 3-km time trial difference.
Plasma [NO3−] and [NO2−]
The group mean plasma [NO3−] values of both supplementation periods are illustrated in Figure 3A. After PLA [NO3−] values were significantly higher in High (28.3 ± 2.1 μM) relative to both Mod (23.2 ± 3.8 μM) and Low (21.3 ± 3.4 μM). After NITR plasma [NO3−] values significantly increased in the three groups (93.7 ± 17.1, 140.4 ± 16.8, and 181.7 ± 32.7 μM in High, Mod, and Low, respectively; P < 0.0001). Individual values of plasma [NO3−] in relation to the corresponding V˙O2peak values are shown in Figure 3B both for PLA and NITR. As for PLA, a linear relation was observed between [NO3−] and V˙O2peak, with lower-fit subject showing a lower concentration of nitrate (r2 = 0.58; P < 0.0001). After NITR, an inverse linear relation was observed between the same variables (r2 = 0.73; P < 0.0001).
The group mean plasma [NO2−] values of both supplementation periods are illustrated in Figure 3C. After PLA, no significant differences were observed among the three groups. After NITR, plasma [NO2−] values significantly increased in the three groups with respect to PLA (462.3 ± 249.5, 418.7 ± 266.1, and 265.7 ± 163.7 nM in Low, Mod, and High, respectively; P < 0.0001), whereas no significant differences were observed among the groups. No relationship was found between individual values of plasma [NO2−] and the corresponding V˙O2peak value both for PLA and NITR. A negative linear relationship was observed between the individual increase of plasma [NO2−] after NITR and the corresponding V˙O2peak values (Fig. 3D).
In addition, there was a significant negative correlation between the increase of plasma [NO2−] after NITR and the difference in both O2 cost of submaximal exercise (r2 = 0.49; P = 0.0004; Fig. 4A) and 3-km running time trial performance (r2 = 0.49; P = 0.0004; Fig. 4B).
The main finding of this study is that the individual aerobic fitness levels affect the ergogenic benefits induced by dietary nitrate supplementation. Indeed, our study shows that 6 d of sodium nitrate supplementation (approximately 5.5 mmol·d−1) result in a reduction of oxygen cost of exercise at moderate intensity and an improvement of 3-km running time trial only in subjects with a low-moderate level of aerobic fitness (V˙O2peak <60 mL·kg−1·min−1), whereas no effects were observed in highly trained subjects.
Previous studies have shown that in recreationally active subjects (V˙O2peak approximately 50–55 mL·kg−1·min−1), short periods (3–6 d) of ingestion of either nitrate salts or nitrate-rich beetroot juice reduces oxygen consumption by 3%–14% during steady-state submaximal cycling (2,30,31,41,44), running (28), and knee extensor exercise (1). In addition to improved exercise economy, nitrate supplementation enhanced exercise tolerance by 3%–25% in cycling and running time to exhaustion tests in recreationally active men (2,28,44) and improved performance by 1.2%–3% during cycling time trial tests (11,27) and running (35) in moderately trained individuals. In our study, nitrate supplementation induced a reduced oxygen consumption between 7% and 10% at moderate intensity (80% of GET) without affecting other pulmonary, cardiovascular, and metabolic parameters in moderate-fit subjects. The same effect, but with a larger reduction of oxygen consumption (7%–13%), was observed in low aerobic fitness subjects (V˙O2peak <45 mL·kg−1·min−1). As for 3-km running time trial (presumably carried out at approximately 85% of V˙O2peak), Low and Mod subjects completed the task faster (approximately 1%–4%) after the sodium nitrate supplementation. Thus, our results in sedentary and moderately trained subjects confirm data present in literature.
As for highly trained individuals (V˙O2peak ≥60 mL·kg−1·min−1), recent evidences show that athletes are less likely to positively respond to nitrate supplementation (4,6,12,13,36,43). For example, Peacock et al. (36) found that the consumption (approximately 10 mM) of potassium nitrate 2.5 h before exercise neither reduced submaximal oxygen consumption during a low-intensity exercise nor enhanced 5-km running performance compared with placebo in 10 highly trained cross-country skiers (V˙O2peak ∼ 70 mL·kg−1·min−1). In addition, Boorsma et al. (6) showed that both acute and chronic (8 d) high-dose nitrate supplementation (∼13 to 19 mM) did not reduce running oxygen consumption or improved 1500-m time trial performance in a group of highly trained distance runners (V˙O2peak∼80 mL·kg−1·min−1). In our study, we examined six subjects with a high level of aerobic fitness (V˙O2peak∼72 mL·kg−1·min−1). Six days of sodium nitrate supplementation did not change oxygen consumption, as well as other pulmonary, cardiovascular, and metabolic parameters, in a constant load exercise at moderate intensity (80% of GET). Moreover, the performance on 3-km running time trial was not different from that of placebo. Thus, our results provide further evidence that elite athletes are unlikely to benefit from nitrate supplementation. Overall, when we take into account all the three groups, a strong correlation was observed between the individual V˙O2peak and the exercise responses, i.e., lower-fit subjects showed both a higher reduction of O2 cost of submaximal exercise and a more relevant improvement in 3-km running time trial performance.
It remains unclear which could be the cause(s) responsible for the different ergogenic effects of the same amount of nitrate supplementation in relation to the individual aerobic fitness level. Some authors have suggested that the ergogenic effects of nitrate supplementation are related to enhanced NO bioavailability and it could be hypothesized that elite athletes already have optimal levels of NO due to the following: a) the reduction of NO2− to NO is potentiated in hypoxic (10) and acidic (34) environments (in which the production of NO from the NOS pathway is impaired), whereas endurance training (22), at least by increasing capillary density in skeletal muscle, may preserve muscle oxygenation and thus diminish the likelihood of developing a hypoxic and/or acidic environment in the active muscle; b) the greater eNOS activity found in well-trained subjects (33) may reduce the importance of the NO3−–NO2−–NO pathway in well-trained compared to moderately trained or sedentary individuals; c) owing to the large daily energy expenditure and assuming the consumption of a mixed diet, it is likely that elite athletes have a greater dietary nitrate intake. Thus, the physiological adaptations induced by chronic endurance training and the possible great ingestion of vegetables rich in nitrate may reduce the effectiveness of dietary NO3− supplementation. Interestingly, the effects of nitrate supplementation seem to be more pronounced in type II muscle fibers (14,18). Considering that there is evidence of a correlation between V˙O2max and percentage of type I fibers in the vastus lateralis muscle (e.g., ), it could be hypothesized that the progressive blunting in the effects of nitrate as subjects’ V˙O2peak increased might be linked to a lower proportion of type II fibers.
Regardless of greater endogenous production and/or greater dietary intake, well-trained athletes exhibit higher baseline plasma [NO3−] and [NO2−] values than sedentary or lesser trained subjects (5,42). The data of the current study are in agreement with these findings since we have found that the greater the aerobic fitness level of the subject, the higher was the absolute plasma [NO3−] level after placebo (i.e., baseline value). A novel observation in the present study is that after 6 d of ingestion of the same amount of sodium nitrate (5.5 mmol·d−1), the variation of plasma [NO3−] and [NO2−] is more pronounced in low-fit subjects than in high-fit subjects. We have no clear explanation of the smaller increase of plasma [NO3−] and [NO2−] observed in elite athletes after NITR supplementation. Subjects were asked to refrain from using antibacterial mouthwash; thus, it seems rather unlikely that this feature could be related to modification in the microflora of the oral cavity. A further possibility is that urinary nitrate and nitrite excretion rose more substantially in elite athletes. Unfortunately, nitrate and nitrite urine concentration were not analyzed in the present study, so we cannot exclude that this occurred. Another possibility is that elite athletes have experienced a greater “consumption” of plasma nitrate and nitrite during daily training sessions, since previous studies have reported an effective consumption of these anions during exercise (5,31). In this regard, it should also be considered that after nonexhaustive exercise, nitrate (25) and nitrite (38) levels have been reported to be higher than before exercise, probably due to the shear stress-stimulating NO production in the arginine oxygen-dependent pathway.
Now, even if it remains unclear why the same amount of nitrate ingested causes a different change in [NO3−] and [NO2−] according to the aerobic fitness level of the subjects, the relevant result of this study is that the changes in plasma [NO3−] and [NO2−] seemed to be linked to the improvements in exercise performance. In particular, we found a strong correlation between the change in plasma [NO2−], a biomarker of NO production and availability, and the change in exercise performance after NITR. Our data confirm and extend previous observations obtained in homogeneous groups of well-trained cyclists (43) and rowers (19). Taken together, these findings underline the importance of consuming an appropriate nitrate dose to produce a meaningful increase in plasma [NO2−] and, consequently, to improve exercise performance. It could be hypothesized that elite athletes may require a greater nitrate exposure than others to elicit any positive effects from dietary nitrate; and thus, our results could be explained by an inadequate dose of nitrate supplementation. Nevertheless, even if we did not test the effects of different dose of sodium nitrate on exercise performance, some literature data help us to exclude this possibility. In particular, whereas in recreationally active subjects the existence of a dose-response relationship between the acute amount of nitrate ingested and plasma [NO2−] and reduction of the O2 cost of moderate-intensity exercise has been reported (44), in elite runners, acute and chronic supplementation with high doses of nitrate-rich beetroot juice failed to improve submaximal treadmill running economy or 1500-m time trial performance despite a dramatic increase in plasma [NO3−]. Interestingly, it has also been demonstrated that among elite athletes, there are responders and nonresponders to same amount of nitrate. For example, despite no statistical effects on the whole group, Wilkerson et al. (43), Christensen et al. (13), and Boorsma et al. (6) identified some subjects in which nitrate supplementation enhanced performance (responders). Even if habitual nitrate intake, activity of oral nitrate reductases and other factors have been considered to be responsible, the physiological basis for the apparent existence of responders and nonresponders to nitrate supplementation is presently unclear and requires further study.
Finally, moving our attention from the oxygen cost of constant load submaximal exercise to other typical parameters of oxidative metabolism, we did not observe any significant changes of them after dietary nitrate supplementation independently of the level of the aerobic fitness of the subjects. Indeed, peak oxygen consumption and GET were similar between PLA and NITR in the three groups. This finding is in accordance with several previous studies that have reported no change on maximal oxygen uptake after single or short-term (3–6 d) nitrate supplementation either in the form of sodium nitrate (31) or beetroot juice (2,41,44). Moreover, no alterations in V˙O2 kinetics were observed in the three groups according to previous observations both in moderate trained (2,41) and highly trained subjects (13).
In conclusion, our study shows that the ergogenic effects of nitrate supplementation are significantly related to the individual aerobic fitness level, with no benefits observed on highly trained subjects (V˙O2peak > 60 mL·kg−1·min−1). These different effects on O2 cost of exercise and performance seem related to the relative changes in plasma [NO3−] and [NO2−]. The clear negative relationship between the difference in plasma [NO2−] with NITR compared to PLA and the difference in exercise performance provides further evidence to the notion that nitrate supplementation might be ergogenic if it results in an appreciable increase of plasma [NO2−]. The optimal nitrate-loading regimen required to elevate plasma [NO2−] and to enhance performance in elite athletes is different from that of low-fit subjects and requires further attention.
This research received funding from Italian Sports Medicine Federation.
The authors thank the subjects for their participation and adherence to the experimental protocol.
There is no conflict of interest with any financial organization regarding the material discussed in the manuscript. The results of the present study do not constitute endorsement by the American College of Sports Medicine.
1. Bailey SJ, Fulford J, Vanhatalo A, et al. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J Appl Physiol
. 2010; 109 (1): 135–48.
2. Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the O2
cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol
. 2009; 107 (4): 1144–55.
3. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol
. 1986; 60 (6): 2020–27.
4. Bescòs R, Ferrer-Roca V, Galilea PA, et al. Sodium nitrate supplementation does not enhance performance of endurance athletes. Med Sci Sports Exerc
. 2012; 44 (12): 2400–9.
5. Bescòs R, Rodriguez FA, Iglesias X, Ferrer MD, Iborra E, Pons A. Acute administration of inorganic nitrate reduces V′O2peak
in endurance athletes. Med Sci Sports Exerc
. 2011; 43 (10): 1979–86.
6. Boorsma RK, Whitfield J, Spriet LL. Beetroot juice supplementation does not improve performance in elite 1500-m runners. Med Sci Sports Exerc
. 2014; 46 (12): 2326–34.
7. Breese BC, McNarry MA, Marwood S, Blackwell JR, Bailey SJ, Jones AM. Beetroot juice supplementation speeds O2
uptake kinetics and improves exercise tolerance during severe-intensity exercise initiated from an elevated metabolic rate. Am J Physiol
. 2013; 305 (12): R1441–50.
8. Bryan NS, Hord NG. Dietary nitrates and nitrites. In: Bryan N, editor. Food Nutrition and the Nitric Oxide pathway
. Destech Pub Inc: Lancaster, PA; 2010. pp. 59–77.
9. Carlström M, Larsen FJ, Nyström T, et al. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci U S A
. 2010; 107 (41): 17716–20.
10. Castello PR, David PS, McClure T, Crook Z, Poyton RO. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab
. 2006; 3 (4): 277–87.
11. Cermak NM, Gibala MJ, van Loon LJ. Nitrate supplementation’s improvement of 10-km time-trial performance in trained cyclists. Int J Sport Nutr Exerc Metab
. 2012a; 22 (1): 64–71.
12. Cermak NM, Res P, Stinkens R, Lundberg JO, Gibala MJ, van Loon LJC. No improvement in endurance performance after a single dose of beetroot juice. Int J Sport Nutr Exerc Metab
. 2012b; 22 (6): 470–8.
13. Christensen PM, Nyberg M, Bangsbo J. Influence of nitrate supplementation on V˙O2
kinetics and endurance of elite cyclists. Scand J Med Sci Sports
. 2012; 23 (1): e21–31.
14. Ferguson SK, Hirai DM, Copp SW, et al. Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J Physiol
. 2013; 591 (Pt2): 547–57.
15. Govoni M, Jansson EA, Weitzberg E, Lundberg JO. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide
. 2008; 19 (4): 333–7.
16. Grassi B, Poole DC, Richardson RS, Knight DR, Erickson BK, Wagner PD. Muscle O2
uptake kinetics in humans: implications for metabolic control. J Appl Physiol
. 1996; 80 (3): 988–98.
17. Hellsten Y, Nyberg M, Jensen LG, Mortensen SP. Vasodilator interactions in skeletal muscle blood flow regulation. J Physiol
. 2012; 590 (Pt24): 6297–305.
18. Hernàndez A, Schiffer TA, Ivarsson N, et al. Dietary nitrate increases tetanic [Ca2+
]i and contractile force in mouse fast-twitch muscle. J Physiol
. 2012; 590 (Pt15): 3575–83.
19. Hoon MW, Jones AM, Johnson NA, et al. The effect of variable doses of inorganic nitrate-rich beetroot juice on simulated 2000 m rowing performance in trained athletes. Int J Sports Physiol Perform
. 2014; 9 (4): 615–20.
20. Hoon MW, Johnson NA, Chapman PG, Burke LM. The effect of nitrate supplementation on exercise performance in healthy individuals: a systematic review and meta-analysis. Int J Sport Nutr Exerc Metab
. 2013; 23 (5): 522–32.
21. Ivy JL, Costill DL, Maxwell BD. Skeletal muscle determinants of maximum aerobic power in men. Eur J Appl Physiol Occup Physiol
. 1980; 44 (1): 1–8.
22. Jensen L, Bangsbo J, Hellsten Y. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J Physiol
. 2004; 557 (Pt2): 571–82.
23. Jones AM. Dietary nitrate supplementation and exercise performance. Sports Med
. 2014; 44 (1 Suppl): S35–45.
24. Jones AM, Grassi B, Christensen PM, et al. Slow component of V˙O2
kinetics: mechanistic bases and practical applications. Med Sci Sports Exerc
. 2011; 43 (11): 2046–62.
25. Jungersten L, Ambring A, Wall B, Wennmalm A. Both physical fitness and acute exercise regulate nitric oxide formation in healthy humans. J Appl Physiol
. 1997; 82 (3): 760–64.
26. Kelly J, Fulford J, Vanhatalo A, et al. Effects of short-term dietary nitrate supplementation on blood pressure, O2
uptake kinetics, and muscle and cognitive function in older adults. Am J Regul Integr Comp Physiol
. 2013; 304 (2): R73–83.
27. Lansley KE, Winyard PG, Bailey SJ, et al. Acute dietary nitrate supplementation improves cycling time trial performance. Med Sci Sports Exerc
. 2011a; 43 (6): 1125–31.
28. Lansley KE, Winyard PG, Fulford J, et al. Dietary nitrate supplementation reduces the O2
cost of walking and running: a placebo-controlled study. J Appl Physiol
. 2011b; 110 (3): 591–600.
29. Larsen FJ, Ekblom B, Sahlin K, et al. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med
. 2006; 355 (26): 2792–3.
30. Larsen FJ, Schiffer TA, Borniquel S, et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab
. 2011; 13 (2): 149–59.
31. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol
. 2007; 191 (1): 59–66.
32. Lundberg JO, Carlstrom M, Larsen FJ, Weitzberg E. Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res
. 2011; 89 (3): 525–32.
33. McConell GK, Bradley SJ. Skeletal muscle NOS protein content is increased by exercise training in humans. Am J Physiol
. 2007; 293 (2): R821–8.
34. Modin A, Bjorne H, Herulf M, et al. Nitrite-derived nitric oxide: a possible mediator of ‘acidic-metabolic’ vasodilation. Acta Physiol Scand
. 2001; 171: 9–16.
35. Murphy M, Eliot K, Heuertz RM, Weiss E. Whole beetroot consumption acutely improves running performance. J Acad Nutr Diet
. 2012; 112: 548–52.
36. Peacock O, Tjonna AE, James P, et al. Dietary nitrate does not enhance running performance in elite cross-country skiers. Med Sci Sports Exerc
. 2012; 44 (11): 2213–9.
37. Poole DC, Jones AM. Oxygen uptake kinetics. Compr Physiol
. 2012; 2 (2): 933–96.
38. Rognmo O, Bjornstad TH, Kahrs C, et al. Endothelial function in highly endurance-trained men: effects of acute exercise. J Strength Cond Res
. 2008; 22 (2): 535–42.
39. Rowell AL. Central circulatory adjustment to dynamic exercise. In: Rowell AL, editor. Human Cardiovascular Control
. New York, NY: Oxford University Press; 1993. pp. 162–201.
40. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev
. 2001; 81 (1): 209–37.
41. Vanhatalo A, Bailey SJ, Blackwell JR, et al. Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise. Am J Physiol
. 2010; 299 (4): R1121–31.
42. Vassalle C, Lubrano V, Domenici C, L’Abbate A. Influence of chronic aerobic exercise on microcirculatory flow and nitric oxide in humans. Int J Sports Med
. 2003; 24 (1): 30–5.
43. Wilkerson DP, Hayward GM, Bailey SJ, Vanhatalo A, Blackwell JR, Jones AM. Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well-trained cyclists. Eur J Appl Physiol
. 2012; 112 (12): 4127–34.
44. Wylie LJ, Kelly J, Bailey SJ, et al. Beetroot juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol
. 2013; 115 (3): 325–36.